Transforming Canadians’ lives
Partnering to champion policies that drive the discovery, development and delivery of transformative medicines and vaccines.
BENEFITS OF INNOVATIVE MEDICINES
Real hope for patients and families
New medicines and vaccines save lives and help make our healthcare system more cost‑effective.
Transformation
Preventing or curing disease means extending lives, relieving suffering and improving people’s quality of life.
Safety
Promoting a robust regulatory protocol means ensuring safe and effective medicines for Canadians.
Sustainability
Supporting sustainable healthcare means we all spend more time enjoying life and being productive.
Industry impact In Canada
Better Health Outcomes
46
Innovative Medicines Canada members
103,000
High-quality jobs
$16 billion
Total yearly economic impact
LATEST RESOURCES
Cost Drivers Report 2024: Analysis of Private Drug Plan Trends in Canada
For the second year in a row,
we saw considerable growth
in the number of claimants
with an 8.5% increase, making
it the main driver of overall
cost. This increase in claimants
was balanced by a low single
digit increase in the cost per
claimants of 2.7%. Read the full report.
LATEST PRESS RELEASES
Press Release November 19, 2024
Bristol-Myers Squibb Canada Wins The 2024 Prix Galien Innovative Product Award
CAMZYOS™ RECOGNIZED FOR THE TREATMENT OF obstructive hypertrophic cardiomyopathy Ottawa, November 19, 2024 – Prix Galien Canada is pleased to […]
Press Release November 19, 2024
The Health Research Foundation Announces The 2024 Medal Of Honour And Diversity & Equity in Research Award Winners
DR. MICHAEL HILL WINS THE MEDAL OF HONOUR, DR. SONIA ANAND WINS THE DIVERSITY AND EQUITY IN RESEARCH AWARD Ottawa, […]
Press Release November 15, 2024
Statement from Innovative Medicines Canada on the Committee of Experts to make recommendations on National Pharmacare
We are disappointed to see that, once again, the government has excluded the pharmaceutical industry’s voice from important discussions on […]
Press Release October 15, 2024
Statement from Innovative Medicines Canada on Ontario’s Next Phase of the Life Sciences Strategy
Today’s announcement by the Ontario government of a $146 million investment in the next phase of the Life Sciences Strategy […]
Press Release October 11, 2024
Statement from Innovative Medicines Canada on the passage of Bill C-64, the Pharmacare Act
With the passage of the Pharmacare Act, Innovative Medicines Canada remains concerned that the pharmacare program as outlined in the […]
Press Release October 03, 2024
Statement from Innovative Medicines Canada in response to Minister Holland’s letter to SOCI
“Minister Holland’s recent letter to SOCI regarding the impact of Bill C-64 on private insurance in Canada confirms our concerns: […]
Press Release September 25, 2024
IMC welcomes the Government of Canada’s announcement on the Launch of Health Emergency Readiness Canada (HERC)
Ottawa, September 25, 2024 – Innovative Medicines Canada (IMC) welcomes the announcement of the federal government’s commitment to safeguarding the […]
Press Release July 24, 2024
Innovative Medicines Canada welcomes bilateral agreements between the Government of Canada and Province of British Columbia to improve patient access to drugs for rare diseases
Ottawa, July 24, 2024 – Innovative Medicines Canada (IMC) is encouraged by the announcement that the federal government and the […]
